Table 1.
No | Compound | Oxytosis (EC50) |
Energy Loss (EC50) |
AβToxicity (EC50) |
Trophic Withdrawal (EC50) |
Inflammation (EC50) |
---|---|---|---|---|---|---|
1 | 9ΔTHCA | 8 μM | 20 μM | - | - | >10 μM |
2 | CBDA | >10 μM | 500 nM | 70 nM | 120 nM | >10 μM |
3 | CBGA | - | - | - | - | 9 μM |
4 | 9ΔTHC | 550 nM | 500 nM | 100 nM | 430 nM | 7 μM |
5 | DMCBD | - | - | >1 μM | >5 μM | 9 μM |
6 | CBDV | 1.1 μM | 90 nM | 100 nM | 350 nM | >10 μM |
7 | 8ΔTHC | 400 nM | 60 nM | 85 nM | 275 nM | >10 μM |
8 | CBG | 1.9 μM | 2 μM | 80 nM | >1.5 μM | >10 μM |
9 | CBC | 750 nM | 750 nM | 100 nM | 200 nM | >10 μM |
10 | CBN | 700 nM | 300 nM | 90 nM | 120 nM | >10 μM |
11 | CBD | 610 nM | 200 nM | 30 nM | 75 nM | 10 μM |
EC50 = 50% of maximal protection; Oxytosis and Energy Loss use HT22 cells; Aβ Toxicity uses MC65 cells; Trophic Withdrawal uses primary neurons; Inflammation uses BV2 microglia. THCA, tetrahydrocannabinol acid; CBDA, cannabidiolic acid; CBGA, cannabigerolic acid; Δ9THC; CBD, cannabidiol; CBDV, cannabidivarin, Δ8THC; CBG, cannabigerol; CBC, cannabichromene; CBN, cannabinol; DMCBD, dimethyl cannabidiol. Toxicity at 10 μM is indicated by -. EC50s below 1 μM are shaded in grey.